Natco Pharma Shares Slump 2% as the USFDA Issued 7 Observations
February 13, 2026February 13, 2026 Shares of Natco Pharma Ltd were trading in the red and 2% lower on 13 February after the company announced that the US drug authority had issued seven Form 483 observations for the company’s Chennai API unit. The business stated…
